TE_44
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MLT1C2 |
|---|---|
| TE superfamily | MaLR |
| TE class | LTR |
| Gene | ENSG00000284703 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 4.26 |
| Counts of samples | TCGA_tumor:33; TCGA_normal:2; GTEx:6 |
| TSS | chr1(-):4023833 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_44.1 | ENSG00000284703 | Chimeric | Non-coding | Non-coding | chr1(-):4016686,4016706,4018478,4023044,4023728,4023834 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
